Welcure Drugs & Pharmaceuticals Share Price
Start SIP in Welcure Drugs & Pharmaceuticals
Start SIPWelcure Drugs & Pharmaceuticals Performance
Day Range
- Low 0
- High 0
52 Week Range
- Low 0
- High 0
- Open Price0
- Previous Close0
- Volume
Welcure Drugs & Pharmaceuticals Investment Rating
-
Master Rating:
-
Welcure Drugs & Pharms. has an operating revenue of Rs. 0.17 Cr. on a trailing 12-month basis. An annual revenue de-growth of -63% needs improvement, Pre-tax margin of 0% needs improvement, ROE of -12% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It is currently FORMING a base in its weekly chart and is trading around 0% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 3 which is a POOR score indicating inconsistency in earnings, a RS Rating of 81 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 109 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has some relative strength and buyer demand but we want to see further fundamental performance to qualify as a growth stock. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Welcure Drugs & Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹7.14
- 50 Day
- ₹6.30
- 100 Day
- ₹5.64
- 200 Day
- ₹5.13
- 20 Day
- ₹7.18
- 50 Day
- ₹5.97
- 100 Day
- ₹5.28
- 200 Day
- ₹4.79
Welcure Drugs & Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 7.69 |
| Second Resistance | 7.69 |
| Third Resistance | 7.69 |
| RSI | 78.53 |
| MFI | 100.00 |
| MACD Single Line | 0.55 |
| MACD | 0.54 |
| Support | |
|---|---|
| First Support | 7.69 |
| Second Support | 7.69 |
| Third Supoort | 7.69 |
Welcure Drugs & Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 82,628 | 8,262,800 | 100 |
| Week | 82,628 | 8,262,800 | 100 |
| 1 Month | |||
| 6 Month | 30,729 | 3,033,566 | 98.72 |
Welcure Drugs & Pharmaceuticals Result Highlights
Welcure Drugs & Pharmaceuticals Synopsis
BSE-Medical-Biomed/Biotech
Welcure Drugs & is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 13.44 Cr. for the Year ended 31/03/2024. Welcure Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 06/08/1996 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L24232DL1996PLC227773 and registration number is 227773.| Market Cap | 10 |
| Sales | |
| Shares in Float | 1.35 |
| No of funds | |
| Yield |
| Book Value | 7.69 |
| U/D Vol ratio | |
| LTDebt / Equity | |
| Alpha | 0.28 |
| Beta | 0.85 |
Welcure Drugs & Pharmaceuticals Shareholding Pattern
| Owner Name | Sep-24 | Jun-24 | Mar-24 | Dec-23 |
|---|---|---|---|---|
| Promoters | ||||
| Individual Investors | 93.55% | 93.14% | 93.7% | 93.87% |
| Others | 6.45% | 6.86% | 6.3% | 6.13% |
Welcure Drugs & Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Altaf Hussain Shah | Managing Director & CFO |
| Mrs. Deepika Krishnan Iyer | Ind. Non-Executive Director |
| Mr. Ashish Abbi | Ind. Non-Executive Director |
| Mr. Suraj Chagan Solanki | Non Exe.Non Ind.Director |
Welcure Drugs & Pharmaceuticals Forecast
Price Estimates
Welcure Drugs & Pharmaceuticals Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-10-21 | Others | |
| 2024-08-14 | Quarterly Results | |
| 2024-06-10 | Others | Inter alia, 1. To augment of financial resources of the company, 2. To increase in authorised share capital of the company and 3. To shift branch office of the company. |
| 2024-05-30 | Audited Results | (Revised) |
| 2024-03-28 | Others | Inter alia, (1) To Consider and Approve the Resignation of M/s BMGS &Associates Accountant of the Company. |
Welcure Drugs & Pharmaceuticals FAQs
What is Share Price of Welcure Drugs & Pharmaceuticals ?
Welcure Drugs & Pharmaceuticals share price is ₹7 As on 03 November, 2024 | 01:36
What is the Market Cap of Welcure Drugs & Pharmaceuticals ?
The Market Cap of Welcure Drugs & Pharmaceuticals is ₹10.4 Cr As on 03 November, 2024 | 01:36
What is the P/E ratio of Welcure Drugs & Pharmaceuticals ?
The P/E ratio of Welcure Drugs & Pharmaceuticals is -21.4 As on 03 November, 2024 | 01:36
What is the PB ratio of Welcure Drugs & Pharmaceuticals ?
The PB ratio of Welcure Drugs & Pharmaceuticals is 7.7 As on 03 November, 2024 | 01:36
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.